Hemostasis Today
NewsFeed
Headlines Hematology Health Medicine VTE ASH Plasma Donation
August, 2026
August 2026
M T W T F S S
 12
3456789
10111213141516
17181920212223
24252627282930
31  
Shashank Joshi: Switching Among Oral Anticoagulants
Shashank Joshi/LinkedIn
Feb 2, 2026, 16:45

Shashank Joshi: Switching Among Oral Anticoagulants

Shashank Joshi, Senior Consultant at Joshi Clinic and President of Indian Academy of Diabetes, shared post on LinkedIn:

“Switching among oral anticoagulants

Switching from a DOAC to warfarin

  • Apixaban
    If continuous anticoagulation is needed, discontinue apixaban and start a parenteral anticoagulant with warfarin; continue the parenteral agent until the INR is therapeutic on warfarin (PI). Note that apixaban can contribute to INR elevation.
    -or-
    Overlap warfarin with apixaban until the INR is therapeutic on warfarin, testing right before the next apixaban dose to minimize the effect of apixaban on INR elevation (ASH).
  • Rivaroxaban
    Discontinue rivaroxaban and start a parenteral anticoagulant with warfarin; continue the parenteral agent until the INR is therapeutic on warfarin (PI). Note that rivaroxaban can contribute to INR elevation.
    -or-
    Overlap warfarin with rivaroxaban until the INR is therapeutic on warfarin, testing right before the next rivaroxaban dose to minimize the effect of rivaroxaban on INR elevation (ASH).

Switching from warfarin to a DOAC

  • Rivaroxaban
    Stop warfarin, monitor the PT/INR, and start rivaroxaban when the INR is less than 3 (PI).
  • Apixaban
    Stop warfarin, monitor the PT/INR, and start apixaban when the INR is less than 2 (PI).

Switching from one DOAC to a different DOAC

  • Any DOAC

Start the second DOAC when the next dose of the first DOAC would have been due; do not overlap.”

Shashank Joshi: Switching Among Oral Anticoagulants

Explore more posts for deeper insights into hemostasis with Hemostasis Today.

Apixaban Direct Oral Anticoagulant Hematology Hemostasis Hemostasis Today Oral Anticoagulant Rivaroxaban Shashank Joshi thrombosis Warfarin
NewsFeed